SSHRC Impact Awards are designed to build on and sustain Canada’s research-based knowledge culture in all research areas of the social sciences and humanities. The awards recognize outstanding researchers and celebrate their research achievements, research training, knowledge mobilization, and outreach activities funded partially or entirely by SSHRC.

Award funds are to be used for activities that promote and further develop the work being honoured. In recognition of the crucial role that postsecondary institutions play as researchers’ knowledge mobilization partners, at least 10 per cent of each award must be used to promote the recipient’s research achievements. Individual recipients and their institutions may choose to devote additional funds, including a higher percentage of the award funds, to these activities.

A multidisciplinary jury made up of distinguished individuals from academia, as well as the private, not-for-profit and public sectors, from Canada and abroad, will select award recipients according to the selection criteria associated with each of the five awards listed below.

Prior to announcing the award winners, SSHRC will disclose the names of the finalists for all awards but the Gold Medal. Nominees must, as part of the nomination package, consent to SSHRC using their name and nomination information in related promotional activities.

Eligible institutions are invited to put forward nominations for the:

• Gold Medal ($100,000);
• Talent Award ($50,000);
• Insight Award ($50,000);
• Connection Award ($50,000); and
• Partnership Award ($50,000).

Holland Bloorview Kids Rehabilitation Hospital’s research institute (the Bloorview Research Institute) is now accepting submissions for the prestigious 2019 Pursuit Awardcompetitionthat recognizes outstandingachievements in childhood disability research by PhD students across the globe.

We encourage you to share the information below with eligible students and your colleagues: 

What: The 2019 Pursuit Award competition, recognizing PhD students that are working on improving the lives of kids and youth with a disability. Every year, the Pursuit Award receives applications worldwide that are forward-thinking, innovative, and challenge the borders of childhood disability research.

Eligibility: Current PhD students (no more than six months away from defence) and postdoctoral trainees/recent graduates (within one year of receiving their PhD) who have made significant contributions in applied or clinical childhood disability research. Any applied or clinical research specifically linked to childhood disability is eligible for consideration.

Criteria: Finalists are chosen based on significance of research results, methodological rigour, empirical content, and impact on childhood disability care.

Award: Up to three monetary prizes are awarded and finalists may be eligible for a prestigious post-doctoral fellowship at the Bloorview Research Institute. All finalists are invited to present their research during the annual Pursuit Award ceremony May  14, 2019 at Holland Bloorview Kids Rehabilitation Hospital (Holland Bloorview) and compete for the first place prize. Travel and accommodation costs are covered.

Established in 2004, the internationally recognized Bloorview Research Institute pioneers treatments, technologies, therapies, and innovations for the most meaningful and healthy futures for all kids, youth, and families. It is housed at Holland Bloorview – a world-renowned pediatric rehabilitation and continuing care teaching hospital; fully affiliated with the University of Toronto.

The application deadline is Monday, February 4, 2019 5:00 p.m. EST.

Please refer to the attached application package for full details. For more information, please do not hesitate to contact BRIevents@hollandbloorview.ca.

Please encourage your PhD students and postdoctoral fellows to apply.

Antimicrobial resistance (AMR) has become one of the major global health and development challenges of the 21st century. The threat of AMR is particularly high in resource-limited and high-risk settings. This is linked to weak human and animal health systems; diverse means of food production, processing and consumption; food safety and food security; water, hygiene and sanitation challenges; and the global movement of people and goods.

In response to these challenges, the JPIAMR is launching a joint transnational call for proposals for innovative research projects on new or improved diagnostics and surveillance strategies, tools, technologies and methods. These research projects should address diagnosis of AMR infections in clinical and veterinary settings, or the emergence, surveillance, and/or detection of AMR in humans, animals and the environment. This Call will support research projects that also have the potential for impact in areas where the risk and burden of AMR is greatest, e.g. in LMIC settings in Asia and Africa. Projects are encouraged to use a One Health approach where relevant.

CIHR is investing $1.8 million in this joint programming call. The overall projected call budget is of approx. 20 million Euro.

Context

The New Frontiers in Research Fund (NFRF) will invest $275 million over the next five years, and $65 million ongoing, to support international, interdisciplinary, fast-breaking and high-risk research. It is comprised of three streams to support groundbreaking research: 

• Exploration will generate opportunities for Canada to build strength in high-risk, high-reward and interdisciplinary research;
• Transformation will provide large-scale support for Canada to build strength and leadership in interdisciplinary and transformative research; and 
• International will enhance opportunities for Canadian researchers to participate in research with international partners.

The Canada Research Coordinating Committee (CRCC) designed the fund following a comprehensive national consultation, which involved Canadian researchers, research administrators, stakeholders and the public. The fund is administered by the Tri-agency Institutional Programs Secretariat (TIPS), which is housed within the Social Sciences and Humanities Research Council (SSHRC), on behalf of Canada’s three research granting agencies:  the Canadian Institutes of Health Research (CIHR), the Natural Sciences and Engineering Research Council (NSERC) and SSHRC.    

Description

The objective of this inaugural competition is to generate opportunities for early career researchers (ECRs) to conduct high-risk, high-reward and interdisciplinary research not available through funding opportunities currently offered by the three agencies. It seeks to inspire highly innovative projects that defy current research paradigms, propose a unique scientific direction, bring disciplines together beyond the traditional disciplinary approaches, and/or use different perspectives to solve existing problems. 

Eligibility

For this competition, early career researchers  are defined as individuals who have five years or less experience since their first academic appointment as of the NOI deadline, with the exception of career interruptions (e.g., maternity or parental leave, extended sick leave, clinical training, and family care) that occurred after their appointment. Part-time positions are also taken into consideration. For maternity or parental leave, the five-year window is extended by an amount equal to twice the time interruption taken. In the case of a first academic appointment having been a part-time appointment/position, TIPS will count the years of experience following it at 50% until the time of an appointment to a full-time academic position. Additional details are available in the frequently asked questions.

Applications may be submitted by an individual researcher (the nominated principal investigator) or a team of researchers. In addition to the nominated principal investigator, a team may include one co-principal investigator, and any number of co-applicants, and/or collaborators.

Individuals can participate in only one application as a nominated principal investigator, co-principal investigator, or co-applicant in this competition. Furthermore, for future Exploration competitions, individuals cannot participate as a nominated principal investigator, co-principal investigator or co-applicant on a proposal if they are already a grantee or co-grantee of an Exploration award. This restriction does not apply to collaborators.

The Genomic Applications Partnership Program (GAPP) funds downstream research and development (R&D) projects that address real world opportunities and challenges defined by “Receptor” organizations such as industry, government, or not-for-profit entities. These organizations should be committed to commercializing or implementing the outcomes of the project.

Projects are led by the Receptor organization (Canadian or international) but are active collaborations with a Canadian academic researcher. These projects are co-funded by Receptors and other stakeholders and must have the potential to generate significant social and/or economic benefits for Canada.

The GAPP aims to:

• Accelerate the application of Canadian genomics-derived solutions from academia to real-world opportunities and challenges defined by industry, not-for-profit and public-sector Receptors.
• Channel Canada’s genomics capacity into sustainable innovations that benefit Canadians.
• Enhance the value of Canadian genomics technologies by de-risking and incentivizing follow-on investment from industry and other partners.
• Foster mutually beneficial collaboration and knowledge exchange between Canadian academia and technology receptors.

November 29, 2018 – Global Affairs Canada and the Chinese Ministry of Education are offering short-term scholarships to Canadians wishing to study abroad in China. Scholarships are awarded for studies, research, language studies or a combination of studies and language studies at participating Chinese institutions.

• Program name: Canada-China Scholars’ Exchange Program
• Funding organizations: Global Affairs Canada and the Ministry of Education of the People’s Republic of China
• Target audiences: Canadian students (college, undergraduate and graduate levels in Canada); Canadian faculty members and research staff at a post-secondary institution in Canada; Canadian mid-career professionals
• Number of scholarships: Over 20
• Duration: 4 to 12 months for students; and 8 weeks to 12 months for faculty members and mid-career professionals
• Inclusions: Airfare, tuition fees, monthly living stipend, on-campus accommodation and medical insurance
• Deadline: March 1, 2019

For full program details and to submit an online application, visit: Canada-China Scholars’ Exchange Program.

The Canadian Hemophilia Society (CHS) is proud to put out its call for applications for the 2019-2020 grant period for its research program created in collaboration with Bayer and ADVANCE Canada.

The Canadian Hemophilia Society – Bayer ADVANCE Canada Research Program was created to engage Canadian hemophilia treaters in activities to identify and research key issues in the ageing hemophilia population.

The research program will support studies that aim to:

•             Identify and provide insight into key issues associated with the ageing hemophilia population

•             Identify how management of age-related co-morbidities should be adapted to those with hemophilia

•             Create and deliver evidence-based information to health care practitioners (HCPs), the public and policy makers that will lead to improved care and QoL for older Canadians living with hemophilia

The primary intent of this program is to offer one or two $30,000 research grants, to a maximum of $60,000 for one year.

Applications and Deadline:
All completed application forms and support documents must arrive at the National Office of the Canadian Hemophilia Society on or before February 8, 2019. If the CHS receives the application after the deadline date but it is postmarked on or before the deadline date, then it is considered to have been submitted on time. The names of the successful applicants will be announced in March 2019.

Should a candidate wish to have the ADVANCE Canada Steering Committee review the application prior to submitting it to the CHS, please provide by e-mail a copy of the application to Robert Martone of Glia Scientific Communication at rmartone@gliasc.com . He will act as your liaison with the Steering Committee.

Additional information, the eligibility criteria and conditions for the research program as well as the application form can be found on our website at this link:

https://www.hemophilia.ca/research-chs-bayer-advance-canada-research-program